Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$54.41 - $68.2 $8,324 - $10,434
-153 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$61.66 - $70.16 $4,316 - $4,911
-70 Reduced 31.39%
153 $10,000
Q1 2020

May 13, 2020

SELL
$59.35 - $88.73 $14,778 - $22,093
-249 Reduced 52.75%
223 $14,000
Q4 2019

Feb 12, 2020

BUY
$74.18 - $97.92 $23,366 - $30,844
315 Added 200.64%
472 $42,000
Q3 2019

Nov 14, 2019

SELL
$75.36 - $86.57 $29,088 - $33,416
-386 Reduced 71.09%
157 $12,000
Q2 2019

Aug 07, 2019

BUY
$83.92 - $108.88 $45,568 - $59,121
543 New
543 $46,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.